Christopher M Smith Neogenomics Inc (NEO) insider trading activity

Christopher M Smith is Chief Executive Officer of NEOGENOMICS INC. Currently has a direct ownership of 641,585 shares of NEO, which is worth approximately $6.41 Million. The most recent transaction as insider was on Feb 23, 2025, when has been sold 14,067 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 642K

0.73% 3M change

6.54% 12M change

Total Value Held $6.41 Million

Christopher M Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 23 2025	SELL Payment of exercise price or tax liability	-	14,067 Reduced 2.15%	641,585 Common Stock
Feb 23 2025	BUY Exercise of conversion of derivative security	-	57,413 Added 8.05%	655,652 Common Stock
Aug 15 2024	SELL Payment of exercise price or tax liability	-	33,130 Reduced 4.88%	646,302 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$281,047 $14.86 p/Share	18,913 Reduced 2.91%	631,369 Common Stock
May 11 2024	BUY Exercise of conversion of derivative security	-	96,126 Added 12.39%	679,432 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	-	602,219 Added 50.0%	602,219 Common Stock

Also insider at

AKUS

Akouos, Inc. Healthcare

Director

QDEL

QuidelOrtho Corp Healthcare

Director

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Healthcare

Director

CMS